CN1CCN(C(=O)C2=C[C@@H](C3CC3)C[C@@H](OCc3ccc(CO)cc3)O2)CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?